2017
DOI: 10.5301/tj.5000614
|View full text |Cite
|
Sign up to set email alerts
|

Perioperative HDR Brachytherapy for Reirradiation in Head and Neck Recurrences: Single-institution Experience and Systematic Review

Abstract: IMBT could play an important role in the retreatment of recurrent head and neck cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
34
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
3
2

Relationship

1
4

Authors

Journals

citations
Cited by 32 publications
(34 citation statements)
references
References 38 publications
0
34
0
Order By: Relevance
“…However, even if it has become clear that brachytherapy may also be used in recurrences, especially in already irradiated fields, its specific value in many clinical situations and in particular in the tricky post‐EB recurrent setting is not yet fully exploited. Our previous studies and the survival figures for the recurrences in the present study (eg, 52% 3‐year, 28% 5‐year DSS; see Figure ) demonstrate a certain rate of long‐term survivors and even of cure in clinical situations often considered inoperable, as post‐EB recurrences, with very low toxicity deriving from the reirradiation . In particular, groups I, II, and III discussed below are mostly made up of recurrences for which IRT offers specific advantages according to the disease site and the clinical situations.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…However, even if it has become clear that brachytherapy may also be used in recurrences, especially in already irradiated fields, its specific value in many clinical situations and in particular in the tricky post‐EB recurrent setting is not yet fully exploited. Our previous studies and the survival figures for the recurrences in the present study (eg, 52% 3‐year, 28% 5‐year DSS; see Figure ) demonstrate a certain rate of long‐term survivors and even of cure in clinical situations often considered inoperable, as post‐EB recurrences, with very low toxicity deriving from the reirradiation . In particular, groups I, II, and III discussed below are mostly made up of recurrences for which IRT offers specific advantages according to the disease site and the clinical situations.…”
Section: Discussionmentioning
confidence: 99%
“…This fact, and the substantial absence of severe toxicities from IRT as an exclusive and perioperative treatment, makes it a very useful tool in head and neck oncology. However, IRT remains widely underexploited in daily clinical practice as an exclusive and perioperative treatment, even if it is probably the safest reirradiation modality . This is also because IRT is a multidisciplinary tool at the border between surgery and radiotherapy, and close cooperation between surgeons and radiation oncologists during every phase, from the recommendation of treatment in the tumor board to the implantation in the operating theater and to the prescription and dose painting at the radiotherapy department, is necessary to perform high‐quality IRT.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations